News Sentiment

LDX sentiment intelligence

Lumos Diagnostics Holdings Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed

Weighted score 54 Balanced news tone 27 relevant articles

Exchange ASX Australia

Sector Healthcare Market context

Industry Medical Devices Read-through group

Latest close 0.10 Week of 10 Jul 2026

Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

86/100 classification confidence.

Company focus 27

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-6.7% over one week, -6.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Why Is Lumos Diagnostics (ASX:LDX) on Investors' Radar After a 267% One-Year Rally?

Market Reaction

Price moving ahead of tone

65/100 confidence

Primary event Market update 86/100 classification

One-week reaction -6.7% Price reacting lower

Trend fit Trend inactive -6.7% over four weeks

Fair value 1.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance

Positive 10

Neutral 15

Negative 2

Relevance

Why the article matched

Direct first

Direct company coverage 27

Industry context 0

Sector context 0

Sources

Coverage mix

Publishers

Kalkine 11

The Australian 5

simplywall.st 3

Market source 3

Moomoo 1

Proactive financial news 1

BioWorld News 1

IPO Edge 1

Event Lens

What the news is about

Classified themes

Market update 20

Deals and strategy 3

Earnings 2

Guidance 1

Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline

Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-27 of 27

Kalkine Direct company coverage

Why Is Lumos Diagnostics (ASX:LDX) on Investors' Radar After a 267% One-Year Rally?

Tone: Neutral 50/100
Event: Market update
Published: 03 Jul 2026 07:00
Source: Kalkine

Moomoo Direct company coverage

Lumos Diagnostics Closes AU$5 Million Loan Facility With Two Shareholders

Tone: Neutral 50/100
Event: Market update
Published: 01 Jul 2026 07:00
Source: Moomoo

Kalkine Direct company coverage

Lumos Diagnostics (ASX:LDX) Draws Investor Attention After Director Lifts Stake

Tone: Neutral 50/100
Event: Deals and strategy
Published: 25 Jun 2026 07:00
Source: Kalkine

Kalkine Direct company coverage

Lumos Diagnostics (ASX:LDX): Diagnostics Stock Rebounds as Healthcare Small Caps Find Momentum

Tone: Neutral 50/100
Event: Market update
Published: 19 Jun 2026 07:00
Source: Kalkine

simplywall.st Direct company coverage

Analysts Are Optimistic We'll See A Profit From Lumos Diagnostics Holdings Limited (ASX:LDX)

Tone: Positive 66/100
Event: Earnings
Published: 18 Jun 2026 07:00
Source: simplywall.st

Kalkine Direct company coverage

Lumos Diagnostics (ASX:LDX) Gains US Febridx Traction – Here’s What Happening

Tone: Positive 66/100
Event: Market update
Published: 19 May 2026 07:00
Source: Kalkine

Kalkine Direct company coverage

Lumos Diagnostics (ASX:LDX) Under Spotlight as FebriDx Gains Early U.S. Traction

Tone: Positive 66/100
Event: Market update
Published: 18 May 2026 07:00
Source: Kalkine

Kalkine Direct company coverage

Can Lumos Diagnostics (ASX:LDX) Extend Its 333% Surge Following FDA Momentum?

Tone: Positive 66/100
Event: Market update
Published: 14 May 2026 07:00
Source: Kalkine

Market source Direct company coverage

Lumos Diagnostics raises $265,000 through share purchase plan as FebriDx rollout gathers pace

Tone: Positive 66/100
Event: Market update
Published: 30 Apr 2026 07:00
Source: Market source

simplywall.st Direct company coverage

Insiders In Lumos Diagnostics Holdings Left Out From 11% Price Rise After Disposing Stock

Tone: Neutral 50/100
Event: Market update
Published: 18 Apr 2026 07:00
Source: simplywall.st

Kalkine Direct company coverage

From 700% Gains to Recent Declines: What’s Driving Lumos Diagnostics (ASX: LDX)?

Tone: Neutral 50/100
Event: Market update
Published: 16 Apr 2026 07:00
Source: Kalkine

The Australian Direct company coverage

Broker sees Lumos Diagnostics upside

Tone: Positive 66/100
Event: Market update
Published: 14 Apr 2026 07:00
Source: The Australian

Kalkine Direct company coverage

Lumos Diagnostics (ASX: LDX) Falls Today — Here’s What’s Driving the Decline

Tone: Negative 18/100
Event: Market update
Published: 10 Apr 2026 07:00
Source: Kalkine

The Australian Direct company coverage

Lumos lands lucrative manufacturing deal

Tone: Neutral 50/100
Event: Deals and strategy
Published: 09 Apr 2026 07:00
Source: The Australian

Market source Direct company coverage

A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack

Tone: Neutral 50/100
Event: Earnings
Published: 07 Apr 2026 07:00
Source: Market source

Kalkine Direct company coverage

Lumos Diagnostics Holdings (ASX:LDX) Opportunities and Risks in Point-of-Care Testing

Tone: Negative 34/100
Event: Market update
Published: 30 Mar 2026 07:00
Source: Kalkine

Kalkine Direct company coverage

What Does the A$20M Placement Mean for Lumos Diagnostics (ASX:LDX) Stock Outlook?

Tone: Neutral 50/100
Event: Guidance
Published: 27 Mar 2026 07:00
Source: Kalkine

Proactive financial news Direct company coverage

Lumos Diagnostics secures FDA CLIA waiver for FebriDx, unlocking US$1B market opportunity

Tone: Neutral 50/100
Event: Market update
Published: 27 Mar 2026 07:00
Source: Proactive financial news

The Australian Direct company coverage

Long Shortz with Lumos: FDA approval for FebriDx unlocks billion-dollar opportunity

Tone: Neutral 50/100
Event: Regulatory and legal
Published: 27 Mar 2026 07:00
Source: The Australian

The Australian Direct company coverage

Lumos opens $1b US market for FebriDx diagnostic via CLIA waiver decision

Tone: Neutral 50/100
Event: Market update
Published: 27 Mar 2026 07:00
Source: The Australian

Kalkine Direct company coverage

Lumos Diagnostics (ASX:LDX) Soars 1375% in a Year — Can the FDA CLIA Decision Unlock the Next Leg of Growth?

Tone: Positive 66/100
Event: Market update
Published: 07 Mar 2026 08:00
Source: Kalkine

simplywall.st Direct company coverage

Lumos Diagnostics Holdings Limited (ASX:LDX) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Tone: Positive 66/100
Event: Market update
Published: 27 Jan 2026 08:00
Source: simplywall.st

The Australian Direct company coverage

2026: The road ahead with Lumos Diagnostics

Tone: Neutral 50/100
Event: Market update
Published: 09 Jan 2026 08:00
Source: The Australian

Market source Direct company coverage

Companies Like Lumos Diagnostics Holdings (ASX:LDX) Can Afford To Invest In Growth

Tone: Positive 66/100
Event: Market update
Published: 16 Jul 2025 07:00
Source: Market source

BioWorld News Direct company coverage

Lumos stock rockets 162% on commercialization deal worth $317M

Tone: Neutral 50/100
Event: Deals and strategy
Published: 16 Jul 2025 07:00
Source: BioWorld News

IPO Edge Direct company coverage

Lumos Diagnostics Raises $63M AUD in ASX IPO

Tone: Positive 66/100
Event: Market update
Published: 15 Jul 2021 16:59
Source: IPO Edge

Business Wire Direct company coverage

Lumos Diagnostics Announces IPO

Tone: Neutral 50/100
Event: Market update
Published: 09 Jun 2021 07:00
Source: Business Wire